Page last updated: 2024-08-21

alpha-aminopyridine and Hamartoma Syndrome, Multiple

alpha-aminopyridine has been researched along with Hamartoma Syndrome, Multiple in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Wang, Q; Weisberg, E; Zhao, JJ	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Hamartoma Syndrome, Multiple

Article	Year
The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome. Cell cycle (Georgetown, Tex.), 2013, Dec-01, Volume: 12, Issue:23 Topics: Alleles; Aminopyridines; Animals; Breast Neoplasms; Class Ia Phosphatidylinositol 3-Kinase; Disease Models, Animal; Female; Gene Dosage; Genotype; Hamartoma Syndrome, Multiple; Mice; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Skin Neoplasms	2013

Article

Year

The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome.

Cell cycle (Georgetown, Tex.), 2013, Dec-01, Volume: 12, Issue:23

Topics: Alleles; Aminopyridines; Animals; Breast Neoplasms; Class Ia Phosphatidylinositol 3-Kinase; Disease Models, Animal; Female; Gene Dosage; Genotype; Hamartoma Syndrome, Multiple; Mice; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Skin Neoplasms

2013